Novel therapeutic and/or prophylactic agent for coronavirus infection (COVID-19)
The present invention provides: a novel therapeutic and/or prophylactic agent for coronavirus infection (COVID-19), which comprises 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of the 5-aminolevulinic acid (ALA) or the derivative thereof; and a method for treating and/or prophylactic...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
07.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides: a novel therapeutic and/or prophylactic agent for coronavirus infection (COVID-19), which comprises 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of the 5-aminolevulinic acid (ALA) or the derivative thereof; and a method for treating and/or prophylactic for coronavirus infection (COVID-19), which uses the therapeutic and/or prophylactic agent.
本发明提供包含5-氨基乙酰丙酸(ALA)或其衍生物或者它们的盐的新型冠状病毒感染症(COVID-19)的治疗和/或预防剂、以及使用了该治疗和/或预防剂的新型冠状病毒感染症(COVID-19)的治疗和/或预防方法。 |
---|---|
Bibliography: | Application Number: CN202180029760 |